Ampio gets FDA feedback on proposed modifications to special protocol assessment for Ampion

Ampio gets FDA feedback on proposed modifications to special protocol assessment for Ampion

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced it received guidance from the U.S Food Drug Administration regarding the impact of COVID-19 on its Phase III clinical... Read More

Wednesday December 30, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, FDA

Welltok is COVID-19 communication engine for vaccine manufacturers, insurers, hospitals

Welltok is COVID-19 communication engine for vaccine manufacturers, insurers, hospitals

DENVER --With the greatest public health crisis of our time, it is the responsibility of every healthcare organization to boost COVID-19 testing and vaccine awareness and education campaigns. ... Read More

Thursday December 24, 2020 0 comments Tags: Denver, Welltok, COVID-19, Bob Fabbio

BioIntelliSense BioButton named CES 2021 Best of Innovation Award honoree

BioIntelliSense BioButton named CES 2021 Best of Innovation Award honoree

DENVER -- BioIntelliSense, Inc. announced it has been named Best of Innovation as a CES 2021 Innovation Awards honoree for the BioButton medical-grade wearable device and data services. The "Best... Read More

Monday December 21, 2020 0 comments Tags: Denver, BioIntelliSense, BioButton, James Mault, COVID-19, CES 2021

Ampion demonstrates safety in COVID patients and initiates global trial for intravenous Ampion

Ampion demonstrates safety in COVID patients and initiates global trial for intravenous Ampion

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it hascompleted its Phase I clinical trial and has initiated the first steps for a global Phase II clinical trial for... Read More

Friday December 18, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, COVID-19, Ampion

Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion

Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug,... Read More

Monday December 14, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, FDA, COVID-19

InDevR expands commercial portfolio for coronavirus vaccine characterization 

InDevR expands commercial portfolio for coronavirus vaccine characterization 

BOULDER -- InDevR, Inc. , a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial... Read More

Thursday December 10, 2020 0 comments Tags: Boulder, InDevR, Kathy Rowlen, VaxArray, COVID-19

Ampio's Phase I study for inhaled Ampion advances to completing enrollment of COVID-19 patients

Ampio's Phase I study for inhaled Ampion advances to completing enrollment of COVID-19 patients

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced its AP-014 Phase I inhaled Ampion clinical study in COVID-19 patients is proceeding to full open enrollment following... Read More

Friday December 4, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Michael Macaluso, COVID-19, Inhaled Ampion

Clean Republic expands smart clean movement with consumer launch of EPA and ECHA-approved Disinfectant + Sanitizer

Clean Republic expands smart clean movement with consumer launch of EPA and ECHA-approved Disinfectant + Sanitizer

BOULDER -- Clean Republic, makers of OMRI-certified, nature-derived cleaning products, announced the U.S. consumer launch of their EPA and ECHA-approved Disinfectant + Sanitizer. The product is... Read More

Thursday December 3, 2020 0 comments Tags: Boulder, Clean Republic, COVID-19, Jake Piccoli, Hugh Huffaker